Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Multi Medika Internasional Tbk (ISX:MMIX) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
PT Multi Medika Internasional Tbk EBITDA Margin % Related Terms
PT Multi Medika Internasional Tbk EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Multi Medika Internasional Tbk EBITDA Margin % Chart
PT Multi Medika Internasional Tbk Annual Data
Trend
Dec20
Dec21
EBITDA Margin %
0.00
18.47
PT Multi Medika Internasional Tbk Semi-Annual Data
Dec20
Dec21
EBITDA Margin %
0.00
18.47
PT Multi Medika Internasional Tbk EBITDA Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, PT Multi Medika Internasional Tbk's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Multi Medika Internasional Tbk EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Multi Medika Internasional Tbk's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where PT Multi Medika Internasional Tbk's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Multi Medika Internasional Tbk (ISX:MMIX) has a EBITDA Margin % of 18.47% as of Dec. 2021. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Multi Medika Internasional Tbk and its competitors.
Is PT Multi Medika Internasional Tbk's EBITDA Margin % too high?
PT Multi Medika Internasional Tbk's current EBITDA Margin % is 18.47%. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. PT Multi Medika Internasional Tbk's value of 18.47% is 80.5% above this industry median. Overall, PT Multi Medika Internasional Tbk has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does PT Multi Medika Internasional Tbk's EBITDA Margin % compare to competitors?
PT Multi Medika Internasional Tbk's EBITDA Margin % of 18.47% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.24. PT Multi Medika Internasional Tbk's value of 18.47% is 80.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Multi Medika Internasional Tbk's current EBITDA Margin % of 18.47% is 80.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Multi Medika Internasional Tbk and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Multi Medika Internasional Tbk's current EBITDA Margin % is 18.47%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Multi Medika Internasional Tbk stock overvalued right now?
PT Multi Medika Internasional Tbk (ISX:MMIX) has a current EBITDA Margin % of 18.47%. The current EBITDA Margin % is 18.47% and 80.5% above the Healthcare Providers & Services industry median of 10.24. PT Multi Medika Internasional Tbk's overall GF Score™ is 24/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PT Multi Medika Internasional Tbk (ISX:MMIX), the current EBITDA Margin % is 18.47% as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Multi Medika Internasional Tbk Business Description
PT Multi Medika Internasional Tbk is engaged in the wholesale trading of medical devices and pharmaceutical and laboratory equipment for humans, operating lease, and non-copyrighted works. It also wholesales other food and beverages, such as rice flour, tapioca flour, bakery premix, caramel, processed honey, shrimp crackers and others; agricultural food and beverages, such as herbs and spices; livestock and fisheries; non-alcoholic beverages, such as fruit juice, soft drinks, mineral water, bottled water, and other similar products; cosmetics for humans such as perfume, soap, powder and others. Its segments include Mask and other non food and beverages, and food and beverages. It derives the majoritf of the revenue from Mask and other non food and beverages segments.
24GF Score
Get the complete analysis for ISX:MMIX
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:MMIX has been successfully added to your 
